The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCO 2024 | Treating mantle cell lymphoma: past approaches and future perspectives
In this video, Michael Wang, MD, University of Texas MD Anderson Cancer Center, Houston, TX, briefly discusses the history of mantle cell lymphoma (MCL) treatment and comments on future directions which he hopes will prolong the length of remission and result in cure in a proportion of patients. This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
